Bayer-Backed Boundless Bio Falls 9% After $100 Million IPO [BNN Bloomberg (Canada)]
Goldman Sachs Group, Inc. (The) (GS)
Last goldman sachs group, inc. (the) earnings: 4/15 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
goldmansachs.com/investor-relations
Company Research
Source: BNN Bloomberg
The San Diego-based company's shares declined to $14.59 each as of 1:17 p.m. on Thursday, below their IPO price of $16 — the midpoint of a $15 to $17 marketed range. The trading gives Boundless Bio a market value of about $324 million, based on the outstanding shares listed in its filings with the US Securities and Exchange Commission. Accounting for employee stock options and restricted stock units, the company would have a fully diluted value of around $500 million. Boundless Bio is a clinical-stage oncology company whose therapies target extrachromosomal DNA, which causes certain types of cancers. The company raised $100 million last May in a series C round co-led by Leaps by Bayer and RA Capital Management, according to a statement. ARCH Venture Partners has an 11.2% stake in Boundless Bio after the offering, while Bayer owns 6.6%, the filings show. The offering is being led by Goldman Sachs Group Inc., Leerink Partners, Piper Sandler Cos. and Guggenheim Securities, the fil
Show less
Read more
Impact Snapshot
Event Time:
GS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GS alerts
High impacting Goldman Sachs Group, Inc. (The) news events
Weekly update
A roundup of the hottest topics
GS
News
- Billionaire Miami Dolphins owner wants to make South Florida more like Manhattan—'I still love a challenge' [Fortune]Fortune
- Inside the life of a sports banker: Top dealmakers from Goldman Sachs, PJT, Raine, and more break down the job. [Business Insider]Business Insider
- 15 Best States to Retire in The US Financially [Yahoo! Finance]Yahoo! Finance
- 10 Best Technology Dividend Aristocrats to Buy [Yahoo! Finance]Yahoo! Finance
- Galvanize Real Estate Acquires First Asset in Pioneering Profitable Decarbonization Strategy [Yahoo! Finance]Yahoo! Finance
GS
Earnings
- 4/15/24 - Beat
GS
Sec Filings
- 4/26/24 - Form 424B2
- 4/26/24 - Form 424B2
- 4/26/24 - Form 485BPOS
- GS's page on the SEC website